Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furamag versus Furantoina for acute uncomplicated urinary tract infection in women
2019-002747-14Phase 3Terminated
- Sponsor
- "Olainfarm" AS
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of furazidin in bacterial cystitis (2 arms), sponsored by "Olainfarm" AS. Primary endpoint: Combined clinical and bacteriological response. Started Apr 2021; status: terminated.
02
Drugs
furazidin
03
Conditions
bacterial cystitis
Beyond the preview
Go deeper on 2019-002747-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-002747-14.